R

RiverVest Venture Partners

18 employees

RiverVest is a venture capital firm that focuses on identifying and shaping early-stage life science companies to create shareholder value.

Investor insights

Sectors invested in

Biotechnology52
Health Care38
Medical27
Therapeutics24
Pharmaceutical22
Biopharma16
Medical Device15
Manufacturing9
Life Science7
Clinical Trials5
biotechnology4
Immuno-oncology and drug development3
Electronics3
Marketing3
pharmaceutical2
drug2
sales2
regulatory2
cancer2
Immunotherapeutics2

Funding rounds participated in

$1.8M sweet spot round size

Most of their 79 investments are in rounds between $18M and $50M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Financial Services
Finance
Medical Device Venture Capital
Life sciences Venture Capital
Biopharma Venture Capital
Business Development
Venture Capital

Date founded

2000

Investments made

A

Avalyn Pharma Inc. raised $175M on September 27, 2023

Investors: Surveyor Capital, Vida Ventures, LLC, Novo Holdings, S.R. One Ltd, Wellington Management, Perceptive Advisors and RiverVest Venture Partners

O

OncoResponse Inc. raised $14M on May 18, 2023

Investors: INTERVEST-Mortgage Investment Co., 3B Future Health Fund, Canaan, Takeda UK Limited, ARCH Venture Partners, Bering Capital and RiverVest Venture Partners

S

Spruce Biosciences raised $54M on February 9, 2023

Investors: Armistice Capital LLC, Abingworth, 5AM Ventures, Novo Holdings, HealthCap and RiverVest Venture Partners

V

VentureMedGroup, Ltd. raised undisclosed on January 31, 2023

Investors: Endeavour Vision and RiverVest Venture Partners

A

Alleviant Medical raised $74M on January 26, 2023

Investors: TMC Venture Fund, Gilmartin Capital LLC, ShangBay Capital, Longview Ventures, Vensana Capital and RiverVest Venture Partners

B

Bonum Therapeutics raised $93M on November 15, 2022

Investors: Digitalis Ventures, Codon Capital, Vivo Capital and RiverVest Venture Partners

B

BlueJay Therapeutics raised $41M on August 16, 2022

Investors: Octagon Capital Advisors and RiverVest Venture Partners

G

Good Therapeutics, Inc. raised $8M on December 30, 2021

Investors: Digitalis Ventures and RiverVest Venture Partners

V

VentureMedGroup, Ltd. raised undisclosed on November 23, 2021

Investors: Endeavour Vision and RiverVest Venture Partners

B

Biolinq raised $100M on November 2, 2021

Investors: The Broe Group, Global Health Funds, JDRF T1D Fund, M Ventures, Hikma Ventures, Longevity Vision Fund and RiverVest Venture Partners

FAQ